2025
SJR Q2
JCR Q2 · 2,4
94 matched articles
SCIE
Journal detail
Chirality
- Publisher
- Wiley-Liss Inc.
- Country
- United States · Northern America
- Type
- journal
- ISSN
-
089900421520636X
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,62
- Quartile Q2
- H-Index 87
- Cites/doc 2,35
- Docs (3y) 309
- Cites (3y) 808
Clarivate
Web of Science · JCR · 2025
- JCR Q Q2
- JIF 2,4
- 5Y JIF 2,2
- JCI 0,56
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Analytical Chemistry Q2
- Catalysis Q2
- Drug Discovery Q2
- Organic Chemistry Q2
- Pharmacology Q3
- Spectroscopy Q2
Areas
- Chemical Engineering
- Chemistry
- Pharmacology, Toxicology and Pharmaceutics
WoS categories
- Chemistry, Medicinal | Chemistry, Analytical | Chemistry, Organic | Pharmacology & Pharmacy
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | Q2 | 0,62 | 2,4 | 2,2 | 0,56 | Q2 | 87 |
| 2024 | Q2 | Q1 | 0,682 | 3 | 2,3 | 0,67 | Q2 | 84 |
| 2023 | Q2 | Q1 | 0,438 | 2,8 | 2,2 | 0,6 | Q2 | 84 |
| 2022 | Q3 | Q3 | 0,382 | 2 | 1,9 | 0,52 | Q2 | 84 |
| 2021 | Q3 | Q3 | 0,397 | 2,2 | 2,3 | 0,6 | Q2 | 84 |
| 2020 | Q3 | Q3 | 0,43 | 2,4 | 2,2 | 0,64 | Q2 | 84 |
| 2019 | Q3 | Q3 | 0,439 | 2,2 | 1,8 | 0,69 | Q2 | 84 |
| 2018 | — | Q3 | — | 1,9 | 1,9 | 0,63 | Q2 | — |
| 2017 | Q2 | Q3 | 0,536 | 1,8 | 1,8 | 0,66 | Q2 | 84 |
| 2016 | Q2 | Q3 | 0,677 | 2 | 1,8 | — | — | 84 |
| 2015 | Q2 | Q2 | 0,63 | 2 | 1,7 | — | — | 84 |
| 2014 | Q2 | Q3 | 0,572 | 1,9 | 1,9 | — | — | 84 |
| 2013 | Q2 | Q3 | 0,686 | 1,7 | 2,1 | — | — | 84 |
| 2012 | Q2 | Q3 | 0,656 | 1,9 | 2,2 | — | — | 84 |
| 2011 | Q2 | Q2 | 0,932 | 2,4 | 2,2 | — | — | 84 |
| 2010 | Q2 | Q1 | 0,904 | 2,9 | 2,5 | — | — | 84 |
| 2009 | — | Q1 | — | 2,7 | 2,3 | — | — | — |
| 2008 | — | Q2 | — | 2,2 | 2,2 | — | — | — |
| 2007 | — | Q2 | — | 2,4 | 2,2 | — | — | — |
| 2006 | — | Q2 | — | 2,2 | — | — | — | — |
| 2005 | — | Q2 | — | 2,1 | — | — | — | — |
| 2004 | — | Q2 | — | 2 | — | — | — | — |
| 2003 | — | Q2 | — | 1,8 | — | — | — | — |
| 2002 | — | Q2 | — | 1,6 | — | — | — | — |
| 2001 | — | Q2 | — | 1,6 | — | — | — | — |
| 2000 | — | Q2 | — | 1,6 | — | — | — | — |
| 1999 | — | Q2 | — | 1,3 | — | — | — | — |
| 1998 | — | Q2 | — | 1,5 | — | — | — | — |
| 1997 | — | Q1 | — | 1,9 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | CHEMISTRY, ANALYTICAL | SCIE | Q3 | Q3 | 71/110 |
| 2025 | CHEMISTRY, MEDICINAL | SCIE | Q3 | Q3 | 52/72 |
| 2025 | CHEMISTRY, ORGANIC | SCIE | Q2 | Q2 | 25/58 |
| 2025 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q3 | 215/356 |
| 2024 | CHEMISTRY, ANALYTICAL | SCIE | Q2 | Q2 | 49/111 |
| 2024 | CHEMISTRY, MEDICINAL | SCIE | Q3 | Q3 | 44/72 |
| 2024 | CHEMISTRY, ORGANIC | SCIE | Q1 | Q2 | 12/57 |
| 2024 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 138/352 |
| 2023 | CHEMISTRY, ANALYTICAL | SCIE | Q2 | Q3 | 46/106 |
| 2023 | CHEMISTRY, MEDICINAL | SCIE | Q3 | Q3 | 42/72 |
| 2023 | CHEMISTRY, ORGANIC | SCIE | Q1 | Q2 | 14/58 |
| 2023 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q3 | 158/354 |
| 2022 | CHEMISTRY, ANALYTICAL | SCIE | Q3 | Q3 | 59/86 |
| 2022 | CHEMISTRY, MEDICINAL | SCIE | Q4 | Q4 | 47/60 |
| 2022 | CHEMISTRY, ORGANIC | SCIE | Q3 | Q2 | 30/52 |
| 2022 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q3 | 218/278 |
| 2021 | CHEMISTRY, ANALYTICAL | SCIE | Q3 | Q2 | 64/87 |
| 2021 | CHEMISTRY, MEDICINAL | SCIE | Q4 | Q3 | 51/63 |
| 2021 | CHEMISTRY, ORGANIC | SCIE | Q3 | Q2 | 32/56 |
| 2021 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q3 | 222/279 |
| 2020 | CHEMISTRY, ANALYTICAL | SCIE | Q3 | Q2 | 56/87 |
| 2020 | CHEMISTRY, MEDICINAL | SCIE | Q3 | Q3 | 46/62 |
| 2020 | CHEMISTRY, ORGANIC | SCIE | Q3 | Q2 | 29/57 |
| 2020 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q3 | 202/276 |
| 2019 | CHEMISTRY, ANALYTICAL | SCIE | Q3 | Q2 | 47/86 |
| 2019 | CHEMISTRY, MEDICINAL | SCIE | Q3 | Q3 | 40/61 |
| 2019 | CHEMISTRY, ORGANIC | SCIE | Q3 | Q2 | 29/57 |
| 2019 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 183/271 |
| 2018 | CHEMISTRY, ANALYTICAL | SCIE | Q3 | Q2 | 51/84 |
| 2018 | CHEMISTRY, MEDICINAL | SCIE | Q3 | Q3 | 45/61 |
| 2018 | CHEMISTRY, ORGANIC | SCIE | Q3 | Q2 | 32/57 |
| 2018 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q3 | 185/267 |
| 2017 | CHEMISTRY, ANALYTICAL | SCIE | Q3 | Q2 | 45/81 |
| 2017 | CHEMISTRY, MEDICINAL | SCIE | Q4 | Q3 | 45/59 |
| 2017 | CHEMISTRY, ORGANIC | SCIE | Q3 | Q2 | 34/57 |
| 2017 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q3 | 191/261 |
| 2016 | CHEMISTRY, ANALYTICAL | SCIE | Q3 | — | 40/76 |
| 2016 | CHEMISTRY, MEDICINAL | SCIE | Q3 | — | 40/60 |
| 2016 | CHEMISTRY, ORGANIC | SCIE | Q3 | — | 34/59 |
| 2016 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 167/257 |
| 2015 | CHEMISTRY, ANALYTICAL | SCIE | Q2 | — | 37/75 |
| 2015 | CHEMISTRY, MEDICINAL | SCIE | Q3 | — | 37/59 |
| 2015 | CHEMISTRY, ORGANIC | SCIE | Q3 | — | 32/59 |
| 2015 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 153/255 |
| 2014 | CHEMISTRY, ANALYTICAL | SCIE | Q3 | — | 40/74 |
| 2014 | CHEMISTRY, MEDICINAL | SCIE | Q3 | — | 37/59 |
| 2014 | CHEMISTRY, ORGANIC | SCIE | Q3 | — | 34/58 |
| 2014 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 155/255 |
| 2013 | CHEMISTRY, ANALYTICAL | SCIE | Q3 | — | 41/76 |
| 2013 | CHEMISTRY, MEDICINAL | SCIE | Q3 | — | 39/58 |
| 2013 | CHEMISTRY, ORGANIC | SCIE | Q3 | — | 33/58 |
| 2013 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 165/256 |
| 2012 | CHEMISTRY, ANALYTICAL | SCIE | Q3 | — | 41/75 |
| 2012 | CHEMISTRY, MEDICINAL | SCIE | Q3 | — | 34/59 |
| 2012 | CHEMISTRY, ORGANIC | SCIE | Q3 | — | 32/57 |
| 2012 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 161/261 |
| 2011 | CHEMISTRY, ANALYTICAL | SCIE | Q2 | — | 30/73 |
| 2011 | CHEMISTRY, MEDICINAL | SCIE | Q2 | — | 29/59 |
| 2011 | CHEMISTRY, ORGANIC | SCIE | Q2 | — | 28/56 |
| 2011 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 120/261 |
| 2010 | CHEMISTRY, ANALYTICAL | SCIE | Q1 | — | 18/73 |
| 2010 | CHEMISTRY, MEDICINAL | SCIE | Q2 | — | 16/54 |
| 2010 | CHEMISTRY, ORGANIC | SCIE | Q2 | — | 18/56 |
| 2010 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 82/252 |
| 2009 | CHEMISTRY, ANALYTICAL | SCIE | Q1 | — | 16/70 |
| 2009 | CHEMISTRY, MEDICINAL | SCIE | Q2 | — | 18/46 |
| 2009 | CHEMISTRY, ORGANIC | SCIE | Q2 | — | 19/57 |
| 2009 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 95/237 |
| 2008 | CHEMISTRY, ANALYTICAL | SCIE | Q2 | — | 25/70 |
| 2008 | CHEMISTRY, MEDICINAL | SCIE | Q2 | — | 20/41 |
| 2008 | CHEMISTRY, ORGANIC | SCIE | Q2 | — | 24/55 |
| 2008 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 115/219 |
| 2007 | CHEMISTRY, ANALYTICAL | SCIE | Q2 | — | 22/70 |
| 2007 | CHEMISTRY, MEDICINAL | SCIE | Q2 | — | 16/41 |
| 2007 | CHEMISTRY, ORGANIC | SCIE | Q2 | — | 22/56 |
| 2007 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 78/205 |
| 2006 | CHEMISTRY, ANALYTICAL | SCIE | Q2 | — | 23/68 |
| 2006 | CHEMISTRY, MEDICINAL | SCIE | Q2 | — | 15/35 |
| 2006 | CHEMISTRY, ORGANIC | SCIE | Q2 | — | 26/56 |
| 2006 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 93/199 |
| 2005 | CHEMISTRY, ANALYTICAL | SCIE | Q2 | — | 19/70 |
| 2005 | CHEMISTRY, MEDICINAL | SCIE | Q2 | — | 13/34 |
| 2005 | CHEMISTRY, ORGANIC | SCIE | Q2 | — | 23/55 |
| 2005 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 83/193 |
| 2004 | CHEMISTRY, ANALYTICAL | SCIE | Q2 | — | 23/70 |
| 2004 | CHEMISTRY, MEDICINAL | SCIE | Q2 | — | 13/36 |
| 2004 | CHEMISTRY, ORGANIC | SCIE | Q2 | — | 23/58 |
| 2004 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 81/187 |
| 2003 | CHEMISTRY, ANALYTICAL | SCIE | Q2 | — | 25/67 |
| 2003 | CHEMISTRY, MEDICINAL | SCIE | Q2 | — | 16/37 |
| 2003 | CHEMISTRY, ORGANIC | SCIE | Q2 | — | 26/55 |
| 2003 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 91/185 |
| 2002 | CHEMISTRY, ANALYTICAL | SCIE | Q2 | — | 26/68 |
| 2002 | CHEMISTRY, MEDICINAL | SCIE | Q2 | — | 17/35 |
| 2002 | CHEMISTRY, ORGANIC | SCIE | Q3 | — | 29/53 |
| 2002 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 92/188 |
| 2001 | CHEMISTRY, ANALYTICAL | SCIE | Q2 | — | 25/68 |
| 2001 | CHEMISTRY, MEDICINAL | SCIE | Q2 | — | 17/36 |
| 2001 | CHEMISTRY, ORGANIC | SCIE | Q2 | — | 25/51 |
| 2001 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 78/186 |
| 2000 | CHEMISTRY, ANALYTICAL | SCIE | Q2 | — | 23/65 |
| 2000 | CHEMISTRY, MEDICINAL | SCIE | Q2 | — | 16/35 |
| 2000 | CHEMISTRY, ORGANIC | SCIE | Q3 | — | 25/48 |
| 2000 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 72/181 |
| 1999 | CHEMISTRY, ANALYTICAL | SCIE | Q2 | — | 28/66 |
| 1999 | CHEMISTRY, MEDICINAL | SCIE | Q3 | — | 16/30 |
| 1999 | CHEMISTRY, ORGANIC | SCIE | Q2 | — | 23/48 |
| 1999 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 79/175 |
| 1998 | CHEMISTRY, ANALYTICAL | SCIE | Q2 | — | 24/65 |
| 1998 | CHEMISTRY, MEDICINAL | SCIE | Q3 | — | 16/30 |
| 1998 | CHEMISTRY, ORGANIC | SCIE | Q2 | — | 20/45 |
| 1998 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 67/178 |
| 1997 | CHEMISTRY, ANALYTICAL | SCIE | Q1 | — | 15/61 |
| 1997 | CHEMISTRY, MEDICINAL | SCIE | Q2 | — | 8/28 |
| 1997 | CHEMISTRY, ORGANIC | SCIE | Q2 | — | 14/43 |
| 1997 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 39/157 |